{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:21:30Z","timestamp":1793902890509,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Istanbul University-Cerrahpasa, BAP","award":["IUC-BAP 34517"],"award-info":[{"award-number":["IUC-BAP 34517"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91073-1","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:24:34Z","timestamp":1740367474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Isolation and characterization of new lytic bacteriophage PSA-KC1 against Pseudomonas aeruginosa isolates from cystic fibrosis patients"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-7908","authenticated-orcid":false,"given":"K\u00fcbra Can","family":"Kurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7392-527X","authenticated-orcid":false,"given":"Halil","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2440-3125","authenticated-orcid":false,"given":"Edip","family":"Toku\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-1551","authenticated-orcid":false,"given":"Do\u011fukan","family":"\u00d6zbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-7986","authenticated-orcid":false,"given":"Duygu Nur","family":"Arabac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-7932","authenticated-orcid":false,"given":"Sevcan","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-1975","authenticated-orcid":false,"given":"Nevriye","family":"G\u00f6n\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-9260","authenticated-orcid":false,"given":"Mikael","family":"Skurnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-5120","authenticated-orcid":false,"given":"Hrisi Bahar","family":"Tokman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"91073_CR1","doi-asserted-by":"crossref","unstructured":"Venturini, C., Fabijan, P., Fajardo Lubian, A., Barbirz, A. & Iredell, J. S. Biological foundations of successful bacteriophage therapy. EMBO Mol. Med., e12435 (2022).","DOI":"10.15252\/emmm.202012435"},{"key":"91073_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/pharmaceutics14071425","volume":"14","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics. Pharmaceutics 14, 1425 (2022).","journal-title":"Pharmaceutics"},{"key":"91073_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","volume":"8","author":"LL Furfaro","year":"2018","unstructured":"Furfaro, L. L., Payne, M. S. & Chang, B. J. Bacteriophage therapy: clinical trials and regulatory hurdles. Front. Cell. Infect. Microbiol. 8, 376 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"91073_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jgar.2019.09.018","volume":"21","author":"T Anand","year":"2020","unstructured":"Anand, T. et al. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. J. Global Antimicrob. Resist. 21, 34\u201341 (2020).","journal-title":"J. Global Antimicrob. Resist."},{"key":"91073_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-019-1443-5","volume":"19","author":"J Jeon","year":"2019","unstructured":"Jeon, J., Park, J. H. & Yong, D. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in galleria Mellonella larvae and a mouse model of acute pneumonia. BMC Microbiol. 19, 1\u201314 (2019).","journal-title":"BMC Microbiol."},{"key":"91073_CR6","doi-asserted-by":"publisher","first-page":"e16963","DOI":"10.1371\/journal.pone.0016963","volume":"6","author":"E Morello","year":"2011","unstructured":"Morello, E. et al. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PloS One. 6, e16963 (2011).","journal-title":"PloS One"},{"key":"91073_CR7","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1128\/AAC.06330-11","volume":"56","author":"F Pouillot","year":"2012","unstructured":"Pouillot, F. et al. Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b: H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob. Agents Chemother. 56, 3568\u20133575 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"91073_CR8","first-page":"309","volume":"17","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int. J. Mol. Med. 17, 309\u2013317 (2006).","journal-title":"Int. J. Mol. Med."},{"key":"91073_CR9","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"373","author":"BP O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan, B. P. & Freedman, S. D. Cystic fibrosis. Lancet 373, 1891\u20131904. https:\/\/doi.org\/10.1016\/S0140-6736(09)60327-5 (2009).","journal-title":"Lancet"},{"key":"91073_CR10","doi-asserted-by":"crossref","unstructured":"\u00dcst\u00fc, Y. & U\u011furlu, M. National early diagnosis and Screen\u0131ng program: cystic fibrosis. Ankara Med. J. 16 (2016).","DOI":"10.17098\/amj.92852"},{"key":"91073_CR11","volume-title":"Cystic Fibrosis Foundation patient registry annual data report","author":"B Alexander","year":"2016","unstructured":"Alexander, B. et al. Cystic Fibrosis Foundation Patient Registry Annual Data Report (Cystic Fibrosis Foundation, 2016)."},{"key":"91073_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1193-9","volume":"15","author":"MM Rafeeq","year":"2017","unstructured":"Rafeeq, M. M. & Murad, H. A. S. Cystic fibrosis: current therapeutic targets and future approaches. J. Translational Med. 15, 1\u20139 (2017).","journal-title":"J. Translational Med."},{"key":"91073_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fimmu.2020.00385","volume":"11","author":"SA Riquelme","year":"2020","unstructured":"Riquelme, S. A., Wong Fok Lung, T. & Prince, A. Pulmonary pathogens adapt to immune signaling metabolites in the airway. Front. Immunol. 11, 385 (2020).","journal-title":"Front. Immunol."},{"key":"91073_CR14","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3390\/ma12244093","volume":"12","author":"ME Chirgwin","year":"2019","unstructured":"Chirgwin, M. E., Dedloff, M. R., Holban, A. M. & Gestal, M. C. Novel therapeutic strategies applied to Pseudomonas aeruginosa infections in cystic fibrosis. Materials 12, 4093 (2019).","journal-title":"Materials"},{"key":"91073_CR15","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/jcm9123800","volume":"9","author":"M Garcia-Clemente","year":"2020","unstructured":"Garcia-Clemente, M. et al. Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases. J. Clin. Med. 9, 3800 (2020).","journal-title":"J. Clin. Med."},{"key":"91073_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5578\/mb.24165","volume":"50","author":"A G\u00fcndo\u011fdu","year":"2016","unstructured":"G\u00fcndo\u011fdu, A., K\u0131l\u0131\u00e7, H., ULU KILI\u00c7, A. & KUTATELADZE, M. Komplike Deri ve Yumu\u015fak Doku Enfeksiyonu Etkeni \u00c7oklu diren\u00e7li Patojenlerin Standart Bakteriyofaj Kokteyllerine Kar\u015f\u0131 Duyarl\u0131l\u0131klar\u0131n\u0131n Ara\u015ft\u0131r\u0131lmas\u0131. Mikrobiyoloji B\u00fclteni. 50, 215\u2013223 (2016).","journal-title":"Mikrobiyoloji B\u00fclteni"},{"key":"91073_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5578\/mb.3790","volume":"47","author":"F Sahin","year":"2013","unstructured":"Sahin, F., Karasartova, D., Ozsan, T. M., Ger\u00e7eker, D. & K\u0131yan, M. Identification of a novel lytic bacteriophage obtained from clinical MRSA isolates and evaluation of its antibacterial activity. Mikrobiyoloji Bulteni. 47, 27\u201334 (2013).","journal-title":"Mikrobiyoloji Bulteni"},{"key":"91073_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2672.2011.05003.x","volume":"111","author":"D Harper","year":"2011","unstructured":"Harper, D. & Enright, M. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J. Appl. Microbiol. 111, 1\u20137 (2011).","journal-title":"J. Appl. Microbiol."},{"key":"91073_CR19","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s10096-012-1691-x","volume":"31","author":"A Vieira","year":"2012","unstructured":"Vieira, A. et al. Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments. Eur. J. Clin. Microbiol. Infect. Dis. 31, 3241\u20133249 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"91073_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","volume":"47","author":"N Law","year":"2019","unstructured":"Law, N. et al. Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection 47, 665\u2013668 (2019).","journal-title":"Infection"},{"key":"91073_CR21","doi-asserted-by":"publisher","first-page":"e60575","DOI":"10.1371\/journal.pone.0060575","volume":"8","author":"C Essoh","year":"2013","unstructured":"Essoh, C. et al. The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS One. 8, e60575 (2013).","journal-title":"PLoS One"},{"key":"91073_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/v9110328","volume":"9","author":"J Villarroel","year":"2017","unstructured":"Villarroel, J., Larsen, M. V., Kilstrup, M. & Nielsen, M. Metagenomic analysis of therapeutic PYO phage cocktails from 1997 to 2014. Viruses 9, 328 (2017).","journal-title":"Viruses"},{"key":"91073_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fmicb.2019.00574","volume":"10","author":"P Manohar","year":"2019","unstructured":"Manohar, P., Tamhankar, A. J., Lundborg, C. S. & Nachimuthu, R. Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Front. Microbiol. 10, 574 (2019).","journal-title":"Front. Microbiol."},{"key":"91073_CR24","doi-asserted-by":"publisher","first-page":"123965","DOI":"10.1016\/j.biortech.2020.123965","volume":"318","author":"S Aydin","year":"2020","unstructured":"Aydin, S. & Can, K. Pyophage cocktail for the biocontrol of membrane fouling and its effect in aerobic microbial biofilm community during the treatment of antibiotics. Bioresour. Technol. 318, 123965 (2020).","journal-title":"Bioresour. Technol."},{"key":"91073_CR25","first-page":"41","volume-title":"Practical advice on the one-step growth curve","author":"AM Kropinski","year":"2018","unstructured":"Kropinski, A. M. Practical Advice on the one-step Growth CurveVolume 341\u201347 (Methods and Protocols, 2018)."},{"key":"91073_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1085\/jgp.22.3.365","volume":"22","author":"EL Ellis","year":"1939","unstructured":"Ellis, E. L. & Delbruck, M. The growth of bacteriophage. J. Gen. Physiol. 22, 365\u2013384 (1939).","journal-title":"J. Gen. Physiol."},{"key":"91073_CR27","doi-asserted-by":"publisher","first-page":"e0118557","DOI":"10.1371\/journal.pone.0118557","volume":"10","author":"M Khan Mirzaei","year":"2015","unstructured":"Khan Mirzaei, M. & Nilsson, A. S. Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS One. 10, e0118557 (2015).","journal-title":"PLoS One"},{"key":"91073_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/pathogens10030373","volume":"10","author":"I Kyriakidis","year":"2021","unstructured":"Kyriakidis, I., Vasileiou, E., Pana, Z. D. & Tragiannidis, A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens 10, 373 (2021).","journal-title":"Pathogens"},{"key":"91073_CR29","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068\u20132069 (2014).","journal-title":"Bioinformatics"},{"key":"91073_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0401-z","volume":"6","author":"G Arango-Argoty","year":"2018","unstructured":"Arango-Argoty, G. et al. DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data. Microbiome 6, 1\u201315 (2018).","journal-title":"Microbiome"},{"key":"91073_CR31","doi-asserted-by":"publisher","first-page":"W54","DOI":"10.1093\/nar\/gkw413","volume":"44","author":"TM Lowe","year":"2016","unstructured":"Lowe, T. M. & Chan, P. P. tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res. 44, W54\u2013W57 (2016).","journal-title":"Nucleic Acids Res."},{"key":"91073_CR32","doi-asserted-by":"publisher","first-page":"e00359","DOI":"10.1128\/mSphere.00359-16","volume":"2","author":"Y Nishimura","year":"2017","unstructured":"Nishimura, Y. et al. Environmental viral genomes shed new light on virus-host interactions in the ocean. MSphere 2, e00359\u2013e00316 (2017).","journal-title":"MSphere"},{"key":"91073_CR33","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1093\/nar\/29.17.3583","volume":"29","author":"EA Lesnik","year":"2001","unstructured":"Lesnik, E. A. et al. Prediction of rho-independent transcriptional terminators in Escherichia coli. Nucleic Acids Res. 29, 3583\u20133594 (2001).","journal-title":"Nucleic Acids Res."},{"key":"91073_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00818163","volume":"125","author":"IL Hofacker","year":"1994","unstructured":"Hofacker, I. L. et al. Fast folding and comparison of RNA secondary structures. Monatshefte F\u00fcr Chemie\/Chemical Monthly. 125, 167\u2013188 (1994).","journal-title":"Monatshefte F\u00fcr Chemie\/Chemical Monthly"},{"key":"91073_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1006\/jmbi.2001.5102","volume":"313","author":"D Gautheret","year":"2001","unstructured":"Gautheret, D. & Lambert, A. Direct RNA motif definition and identification from multiple sequence alignments using secondary structure profiles. J. Mol. Biol. 313, 1003\u20131011 (2001).","journal-title":"J. Mol. Biol."},{"key":"91073_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1006\/jmbi.2001.5368","volume":"316","author":"C Duffy","year":"2002","unstructured":"Duffy, C. & Feiss, M. The large subunit of bacteriophage \u039b\u2019s terminase plays a role in DNA translocation and packaging termination. J. Mol. Biol. 316, 547\u2013561 (2002).","journal-title":"J. Mol. Biol."},{"key":"91073_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrmicro2632","volume":"9","author":"SR Casjens","year":"2011","unstructured":"Casjens, S. R. The DNA-packaging nanomotor of tailed bacteriophages. Nat. Rev. Microbiol. 9, 647\u2013657 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"91073_CR38","doi-asserted-by":"crossref","unstructured":"Li, B. & Webster, T. J. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J. Orthop. Research\u00ae. 36, 22\u201332 (2018).","DOI":"10.1002\/jor.23656"},{"key":"91073_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tim.2018.08.006","volume":"27","author":"PA de Jonge","year":"2019","unstructured":"de Jonge, P. A., Nobrega, F. L., Brouns, S. J. & Dutilh, B. E. Molecular and evolutionary determinants of bacteriophage host range. Trends Microbiol. 27, 51\u201363 (2019).","journal-title":"Trends Microbiol."},{"key":"91073_CR40","unstructured":"Pirnay, J. P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol., 1\u201320 (2024)."},{"key":"91073_CR41","doi-asserted-by":"publisher","first-page":"O983","DOI":"10.1111\/1469-0691.12712","volume":"20","author":"E Saussereau","year":"2014","unstructured":"Saussereau, E. et al. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients. Clin. Microbiol. Infect. 20, O983\u2013O990 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"91073_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fmicb.2018.00775","volume":"9","author":"M Rossitto","year":"2018","unstructured":"Rossitto, M., Fiscarelli, E. V. & Rosati, P. Challenges and promises for planning future clinical research into bacteriophage therapy against Pseudomonas aeruginosa in cystic fibrosis. An argumentative review. Front. Microbiol. 9, 775 (2018).","journal-title":"Front. Microbiol."},{"key":"91073_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-25576-6","volume":"12","author":"V Lerdsittikul","year":"2022","unstructured":"Lerdsittikul, V. et al. A novel virulent litunavirus phage possesses therapeutic value against multidrug resistant Pseudomonas aeruginosa. Sci. Rep. 12, 1\u201316 (2022).","journal-title":"Sci. Rep."},{"key":"91073_CR44","doi-asserted-by":"crossref","unstructured":"Wannasrichan, W. et al. Phage-resistant Pseudomonas aeruginosa against a novel lytic phage JJ01 exhibits hypersensitivity to colistin and reduces biofilm production. Front. Microbiol. 13 (2022).","DOI":"10.3389\/fmicb.2022.1004733"},{"key":"91073_CR45","doi-asserted-by":"publisher","first-page":"e01832","DOI":"10.1128\/JVI.01832-20","volume":"95","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Novel lytic phages protect cells and mice against pseudomonas aeruginosa infection. J. Virol. 95, e01832\u2013e01820 (2021).","journal-title":"J. Virol."},{"key":"91073_CR46","volume-title":"in C107. MICROBIAL RESPIRATORY INFECTIONS DISCOVERIES A6808-A6808","author":"G Stanley","year":"2024","unstructured":"Stanley, G. et al. In C107. MICROBIAL RESPIRATORY INFECTIONS DISCOVERIES A6808-A6808 (American Thoracic Society, 2024)."},{"key":"91073_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","volume":"4","author":"L Kvachadze","year":"2011","unstructured":"Kvachadze, L. et al. Evaluation of lytic activity of Staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb. Biotechnol. 4, 643\u2013650 (2011).","journal-title":"Microb. Biotechnol."},{"key":"91073_CR48","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/v13101901","volume":"13","author":"E Zaldastanishvili","year":"2021","unstructured":"Zaldastanishvili, E. et al. Phage therapy experience at the Eliava phage therapy center: three cases of bacterial persistence. Viruses 13, 1901 (2021).","journal-title":"Viruses"},{"key":"91073_CR49","volume-title":"in B29. INFECTION AND IMMUNE INTERPLAY IN LUNG INJURY A2977-A2977","author":"G Stanley","year":"2020","unstructured":"Stanley, G. et al. In B29. INFECTION AND IMMUNE INTERPLAY IN LUNG INJURY A2977-A2977 (American Thoracic Society, 2020)."},{"key":"91073_CR50","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/cid\/cix184","volume":"64","author":"N Dufour","year":"2017","unstructured":"Dufour, N., Delattre, R., Ricard, J. D. & Debarbieux, L. The Lysis of pathogenic Escherichia coli by bacteriophages releases less endotoxin than by \u03b2-lactams. Clin. Infect. Dis. 64, 1582\u20131588 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"91073_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo, C. & Abedon, S. T. Pros and cons of phage therapy. Bacteriophage 1, 111\u2013114 (2011).","journal-title":"Bacteriophage"},{"key":"91073_CR52","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/v10120688","volume":"10","author":"K Moelling","year":"2018","unstructured":"Moelling, K., Broecker, F. & Willy, C. A wake-up call: we need phage therapy now. Viruses 10, 688 (2018).","journal-title":"Viruses"},{"key":"91073_CR53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze, A., Alavidze, Z. & Morris, J. G. Jr Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649\u2013659 (2001).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91073-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T14:45:30Z","timestamp":1740408330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91073"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91073-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6551"}}